These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 18239184)

  • 21. Stroke thrombolysis in England: an age stratified analysis of practice and outcome.
    Bray BD; Campbell J; Hoffman A; Tyrrell PJ; Wolfe CD; Rudd AG
    Age Ageing; 2013 Mar; 42(2):240-5. PubMed ID: 23174425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. International classification of diseases and current procedural terminology codes underestimated thrombolytic use for ischemic stroke.
    Qureshi AI; Harris-Lane P; Siddiqi F; Kirmani JF
    J Clin Epidemiol; 2006 Aug; 59(8):856-8. PubMed ID: 16828680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental modeling of recombinant tissue plasminogen activator effects after ischemic stroke.
    El Amki M; Lerouet D; Coqueran B; Curis E; Orset C; Vivien D; Plotkine M; Marchand-Leroux C; Margaill I
    Exp Neurol; 2012 Dec; 238(2):138-44. PubMed ID: 22921458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
    Al-Khaled M; Matthis C; Eggers J
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-morbid conditions in use of recombinant tissue plasminogen activator (rt-PA) for the treatment of acute ischaemic stroke.
    Nathaniel TI; Cochran T; Chaves J; Fulmer E; Sosa C; Yi S; Fredwall M; Sternberg S; Blackhurst D; Nelson A; Leacock R
    Brain Inj; 2016; 30(10):1261-5. PubMed ID: 27484159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteplase for acute ischemic stroke.
    Gonzales NR; Grotta JC
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):301-18. PubMed ID: 16716092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.
    Huang Y; Sharma VK; Robinson T; Lindley RI; Chen X; Kim JS; Lavados P; Olavarría V; Arima H; Fuentes S; Nguyen HT; Lee TH; Parsons MW; Levi C; Demchuk AM; Bath PM; Broderick JP; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Pandian J; Ricci S; Stapf C; Woodward M; Wang J; Chalmers J; Anderson CS;
    Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous thrombolysis in German stroke units before and after regulatory approval of recombinant tissue plasminogen activator.
    Weimar C; Kraywinkel K; Maschke M; Diener HC;
    Cerebrovasc Dis; 2006; 22(5-6):429-31. PubMed ID: 16912477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. United States trends in thrombolysis for older adults with acute ischemic stroke.
    George BP; Asemota AO; Dorsey ER; Haider AH; Smart BJ; Urrutia VC; Schneider EB
    Clin Neurol Neurosurg; 2015 Dec; 139():16-23. PubMed ID: 26363362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence to guidelines by emergency medical services during transport of stroke patients receiving intravenous thrombolytic infusion.
    Asaithambi G; Chaudhry SA; Hassan AE; Rodriguez GJ; Suri MF; Qureshi AI
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e42-5. PubMed ID: 22572162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous thrombolysis for stroke increases over time at primary stroke centers.
    Prabhakaran S; McNulty M; O'Neill K; Ouyang B
    Stroke; 2012 Mar; 43(3):875-7. PubMed ID: 22135073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time.
    Minnerup J; Wersching H; Ringelstein EB; Schilling M; Schäbitz WR; Wellmann J; Berger K
    Stroke; 2011 Oct; 42(10):2838-43. PubMed ID: 21852612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation.
    Awadh M; MacDougall N; Santosh C; Teasdale E; Baird T; Muir KW
    Stroke; 2010 Sep; 41(9):1990-5. PubMed ID: 20705933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [ASPECTS-DWI, arterial occlusion sites and subtype of acute ischemic stroke have a relation with outcome following intravenous rt-PA therapy].
    Idei M; Sasaki T; Tanabe T; Muraoka K; Terada K; Meguro T; Hirotsune N; Nishino S
    No Shinkei Geka; 2012 Jul; 40(7):585-91. PubMed ID: 22728535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Association between t-PA Administration and In-Hospital Mortality following Acute Ischemic Stroke in Puerto Rican Patients.
    Shah K; Kohrman S; Alkhatib S; González J; Santiago F; Varella M; Zevallos J
    P R Health Sci J; 2016 Dec; 35(4):215-219. PubMed ID: 27898168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exclusion criteria for intravenous thrombolysis in stroke mimics: an observational study.
    Brunser AM; Illanes S; Lavados PM; Muñoz P; Cárcamo D; Hoppe A; Olavarria VV; Delgado I; Díaz V
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1140-5. PubMed ID: 23253534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiplatelet therapy in combination with rt-PA thrombolysis in ischemic stroke (ARTIS): rationale and design of a randomized controlled trial.
    Zinkstok SM; Vermeulen M; Stam J; de Haan RJ; Roos YB
    Cerebrovasc Dis; 2010; 29(1):79-81. PubMed ID: 19907167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.